Subscribe
shutterstock_393927661_marbury
marbury / Shutterstock.com
17 August 2021EuropeBeatriz San Martin and Shishu Chen

NHS v Servier: unlawful means tort claim fails, but the long-running saga continues

In this article, we summarise the Supreme Court’s judgment which upholds the lower courts’ decisions in refusing to allow the NHS to avail itself of the tort of unlawful means against Servier, and we comment on the reasoning of the Supreme Court.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
English High Court allows Servier to re-amend competition defence against NHS
13 October 2016   The English High Court has ruled on a competition case between NHS England and Servier, holding that Servier should be granted permission to re-amend its defence.
Big Pharma
NHS should finance HIV treatment PrEP, English High Court rules
2 August 2016   The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025

More on this story

Big Pharma
English High Court allows Servier to re-amend competition defence against NHS
13 October 2016   The English High Court has ruled on a competition case between NHS England and Servier, holding that Servier should be granted permission to re-amend its defence.
Big Pharma
NHS should finance HIV treatment PrEP, English High Court rules
2 August 2016   The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV.

More on this story

Big Pharma
English High Court allows Servier to re-amend competition defence against NHS
13 October 2016   The English High Court has ruled on a competition case between NHS England and Servier, holding that Servier should be granted permission to re-amend its defence.
Big Pharma
NHS should finance HIV treatment PrEP, English High Court rules
2 August 2016   The English High Court has today said that National Health Service England should finance an important therapy used to treat patients suffering from HIV.

More features

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
Taylor Wessing expands in Europe with Paris team
UPC orders 17-country ban on EOFlow's pumps in Insulet feud
AstraZeneca to appeal invalidated diabetes patent in generics dispute
Commercialising genomic tech in Nigeria
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO